AbbVie (NYSE: ABBV) announced the following on Friday:In consultation with the U.S. Food and Drug Administration (FDA), the U.S. Product ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Management Comments

AbbVie Updates U.S. Labels for VIEKIRA PAK® and TECHNIVIE™October 22, 2015 6:22 PM Market Wrap: Existing Sales Ramp in Sept.; Abbvie Hit on FDA Warning for HCV Drug; Amazon's Q3 Results Stun StreetOctober 22, 2015 5:30 PM Achillion (ACHN) Ramps Higher on FDA Warning for Viekira Pak (ABBV)October 22, 2015 3:19 PM Gilead Sciences (GILD) Pops to Session Highs on Abbvie (ABBV) HeadlinesOctober 22, 2015 3:07 PM FDA Warns of Serious Liver Injury Risk with AbbVie's (ABBV) Viekira PakOctober 22, 2015 3:05 PM